Phathom Pharmaceuticals Logo

Phathom Pharmaceuticals

🇺🇸
PHAT
US71722W1071

Phathom Pharmaceuticals is a US-based biopharmaceutical company specializing in the development of innovative therapies for gastrointestinal diseases. The company focuses on the research and commercialization of new treatment methods for acid-related disorders of the gastrointestinal tract.

Next Quarterly Earnings

Thursday, November 5, 2026
CW 45
Pre-Market
In 70 days

Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

Quiet period starts on October 8, 2026

Stock Price

Frequently asked questions

When will Phathom Pharmaceuticals report its next quarterly earnings?

Phathom Pharmaceuticals is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

When did Phathom Pharmaceuticals last report quarterly earnings?

Phathom Pharmaceuticals last reported quarterly earnings on 7/30/2026 (Q2 2026). Earnings per share (EPS) came in at -0.21 USD.

How often has Phathom Pharmaceuticals beaten expectations?

Phathom Pharmaceuticals has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).

How do I add the Phathom Pharmaceuticals earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$0.06
Actual:
Q2 2026
Missed
Estimate:-$0.18
Actual:-$0.21
Difference:-$0.03
Price reaction (1 day):-22.4 %
Price reaction (7 days):-27.9 %
Q1 2026
Missed
Estimate:-$0.29
Actual:-$0.37
Difference:-$0.08
Price reaction (1 day):-4.9 %
Price reaction (7 days):+3.8 %
Q3 2025
Beat
Estimate:-$0.19
Actual:-$0.08
Difference:+$0.11
Q2 2025
Beat
Estimate:-$0.42
Actual:-$0.15
Difference:+$0.27
Q1 2025
Beat
Estimate:-$0.92
Actual:-$0.79
Difference:+$0.13

Earnings statistics

Estimates vs. results

3/5
Quarters above estimates
60%
Beat rate
-9.1%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Phathom Pharmaceuticals
Ticker Symbol
PHAT
ISIN
US71722W1071
Country
🇺🇸
USA
Sector